Veterinary Biomarkers Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Veterinary Biomarkers Market will experience 9.9% CAGR from 2024 to 2032. This growth is primarily driven by the rising focus on improving livestock health, in line with the increasing prevalence of diseases in farm animals. For instance, according to the World Organization for Animal Health (OIE), over 20% of global livestock production is lost due to diseases annually.

Biomarkers play a crucial role in early disease detection, treatment monitoring, and health assessment in animals, making them essential tools in modern veterinary medicine. The growing demand for efficient and accurate diagnostic tools for livestock is expected to propel the veterinary biomarkers market during the forecast period.

The overall Veterinary Biomarkers Industry is classified based on the animal type, product type, disease type, application, end-user, and region.

The livestock animals segment will grow significantly over 2024-2032. The rising awareness among farmers and veterinarians regarding the importance of animal health management and disease prevention is a key driver for this segment. Livestock animals, including cattle, sheep, and swine, are vital to Global agricultural economy. As a result, the need for effective biomarkers for early disease detection and health monitoring is on the rise. The growing emphasis on sustainable farming practices and ensuring the safety of the food supply chain further underscores the importance of veterinary biomarkers in livestock management.

The biomarkers readers segment will capture a notable share of the veterinary biomarkers market by 2032. These specialized devices are designed to detect and quantify biomarkers in animal samples, providing crucial data for diagnosing and monitoring diseases. Technological advancements in biomarkers readers, such as improved sensitivity, accuracy, and ease of use, are driving their adoption in veterinary clinics, research laboratories, and animal health monitoring programs. The increasing demand for point-of-care diagnostic tools that can deliver rapid results in clinical settings is expected to boost the growth of this segment.

Europe will lead the veterinary biomarkers market with commendable gains throughout 2024-2032. The region's well-established veterinary healthcare infrastructure, in line with significant investment in animal health research, positions Europe as a key player in the market. The high prevalence of livestock diseases and stringent regulations regarding animal health and food safety further drive the demand for veterinary biomarkers. Additionally, government initiatives and support for advancing veterinary diagnostics and animal welfare contribute to the strong growth of the veterinary biomarkers market in the region. The presence of leading companies and research institutions also fosters innovation and production, supporting market expansion.

Product Code: 10491

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of chronic disease
  - 3.2.1.2 Growing pet ownership and spending on animal health
  - 3.2.1.3 Advancements in diagnostic technologies
  - 3.2.1.4 Increasing R and D investment and activities
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Regulatory and ethical challenges
  - 3.2.2.2 High development and validation costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Companion animals
- 5.2.1 Dogs
- 5.2.2 Cats
- 5.2.3 Horses
- 5.2.4 Other companion animals
5.3 Livestock animals
- 5.3.1 Cattle
- 5.3.2 Poultry
- 5.3.3 Swine
- 5.3.4 Other livestock animals

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Biomarker readers
6.3 Biomarker kits and reagents

Chapter 7 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Inflammatory and infectious diseases
7.3 Cardiovascular diseases
7.4 renal diseases
7.5 Cancer
7.6 Other disease type

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Clinical
- 8.2.1 Disease diagnosis
- 8.2.2 Disease monitoring
8.3 Research

Chapter 9 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Veterinary hospitals
9.3 Veterinary clinics
9.4 Research institutes
9.5 Reference laboratories

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 The Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 Saudi Arabia
- 10.6.2 South Africa
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

11.1 Bio-Rad Laboratories, Inc.
11.2 Biomerieux SA
11.3 Bionote USA Inc.
11.4 CUSABIO TECHNOLOGY LLC
11.5 EagleBio
11.6 Gentian Diagnostics ASA
11.7 IDEXX Laboratories Inc.
11.8 Krishgen Biosystems
11.9 Life Diagnostics, Inc.
11.10 Merck KGaA
11.11 Randox Laboratories Ltd.
11.12 Virbac
11.13 Zoetis Inc.